Applied DNA Sciences (APDN) Secures 2-Yr $1M Contract from TheraCann International Benchmark Corp. to Develop Molecular Tracking System

January 25, 2018 5:37 AM

Applied DNA Sciences, Inc. (NASDAQ: APDN) today announced the signing of an initial two-year, $1 million contract with TheraCann International ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found